(Q50632987)

English

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Revankar SG

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Kirkpatrick WR

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

McAtee RK

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Dib OP

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Fothergill AW

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Redding SW

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Rinaldi MG

7

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Hilsenbeck SG

8

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Patterson TF

9

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

American Journal of Medicine

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

105

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

7-11

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

High prevalence of antifungal resistance in Candida spp. from patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Fluconazole-resistant Candida albicans after long-term suppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900137-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(98)00137-5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

release_36mcwliffrht5dgngq67vz5mzq

1 reference

https://api.fatcat.wiki/v0/release/36mcwliffrht5dgngq67vz5mzq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/9688014

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50632987&oldid=1837894248"